|
C1ORF96 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.42741374276056E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32940000008297E-07 |
| Normal-vs-Stage2 |
5.044900E-04 |
| Normal-vs-Stage3 |
1.08010000055003E-07 |
| Normal-vs-Stage4 |
6.17800000046742E-07 |
| Stage1-vs-Stage2 |
8.907600E-02 |
| Stage1-vs-Stage3 |
4.158400E-02 |
| Stage1-vs-Stage4 |
1.288310E-02 |
| Stage2-vs-Stage3 |
5.915800E-01 |
| Stage2-vs-Stage4 |
9.265600E-01 |
| Stage3-vs-Stage4 |
4.033200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20767848446712E-12 |
| Normal-vs-AfricanAmerican |
1.837630E-02 |
| Normal-vs-Asian |
3.984300E-02 |
| Caucasian-vs-AfricanAmerican |
2.681600E-03 |
| Caucasian-vs-Asian |
1.894240E-01 |
| AfricanAmerican-vs-Asian |
1.000990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.06434910568987E-13 |
| Normal-vs-Female |
1.19639999995869E-06 |
| Male-vs-Female |
2.388400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.327600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.53479995379513E-09 |
| Normal-vs-Age(61-80Yrs) |
3.44750006320282E-10 |
| Normal-vs-Age(81-100Yrs) |
4.002300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.120400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.179600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.997800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.107800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.103600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.144200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.468300E-02 |
| Normal-vs-Grade 2 |
2.31629999958294E-07 |
| Normal-vs-Grade 3 |
2.0906999464998E-09 |
| Normal-vs-Grade 4 |
6.99240000345824E-08 |
| Grade 1-vs-Grade 2 |
3.201400E-01 |
| Grade 1-vs-Grade 3 |
3.361400E-01 |
| Grade 1-vs-Grade 4 |
1.660200E-03 |
| Grade 2-vs-Grade 3 |
5.339400E-01 |
| Grade 2-vs-Grade 4 |
1.881310E-03 |
| Grade 3-vs-Grade 4 |
4.236800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.364740E-04 |
| Normal-vs-ccB subtype |
2.19602114270856E-13 |
| ccA subtype-vs-ccB subtype |
2.78080000026826E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.23780011082897E-10 |
| Normal-vs-N1 |
7.179300E-03 |
| N0-vs-N1 |
8.160400E-02 |
|
|
